SB 906 revises Florida’s pharmacy laws to create a new framework for “remote-site pharmacies,” which are locations where medicinal drugs are dispensed by a supervising pharmacist remotely overseeing registered pharmacy technicians. The bill expands the statutory definition of pharmacy to include these remote-site locations and clarifies that a pharmacy department may be considered open even when a pharmacist is not physically present if remote supervision is being provided under the new section. It also authorizes registered pharmacy technicians, in this remote-supervision setting, to handle sales transactions and deliver dispensed drugs.
The bill establishes a permitting process for remote-site pharmacies through the Department of Health and sets operational requirements, including joint ownership or contractual operation with a supervising pharmacy, 24/7 video surveillance, public notice signage, written policies and procedures, and inventory and security protocols. It allows remote-site pharmacies to store, hold, and dispense most medicinal drugs, including controlled substances, but prohibits dispensing Schedule II controlled substances unless a pharmacist is physically present. The prescription department manager must be a licensed or consultant pharmacist, must notify the department of changes within 10 days, and must periodically visit the remote-site pharmacy to inspect operations, address personnel matters, and provide clinical services.
The bill’s impact on state law is to create a new telepharmacy-style model within Florida’s pharmacy licensing and disciplinary statutes, while carving out exceptions to existing restrictions on who may dispense drugs and how many technicians a pharmacist may supervise. It also exempts certain remote-site pharmacy arrangements from current limits on pharmacist presence and from the general rule that a pharmacist may not serve as prescription department manager at more than one location. The Board of Pharmacy is given authority to adopt rules on application, structure, training, and recordkeeping requirements for these facilities.
Overall, the bill appears to be generally supportive of expanding pharmacy access through remote operations, with no recorded committee transcripts or votes indicating formal opposition or support in the provided materials. Because the bill text is highly operational and regulatory, likely points of concern would center on patient safety, controlled-substance handling, supervision adequacy, and security at locations without an on-site pharmacist. The main policy tradeoff is between increased access and flexibility for pharmacies versus maintaining traditional oversight and safeguards.
SB 906 would amend multiple sections of chapter 465, Florida Statutes, to recognize remote-site pharmacies as a licensed pharmacy type and to create new permitting, supervision, and operational rules for them. It would also modify existing pharmacy technician and pharmacy violation provisions to allow registered technicians to perform limited sales and delivery functions under remote supervision, and it would exempt remote-site pharmacy arrangements from certain current restrictions on pharmacist presence and single-location management. The Department of Health and Board of Pharmacy would gain new administrative and rulemaking responsibilities over these facilities.
No committee transcripts or vote records were provided, so there is no documented floor or committee debate to measure directly. Based on the bill text alone, the measure appears to be a modernization and access-oriented proposal that likely aims to expand pharmacy services in underserved or low-traffic settings. The absence of recorded opposition in the supplied materials suggests no clear public sentiment can be inferred beyond the bill’s apparent intent to facilitate remote pharmacy operations while preserving pharmacist oversight.
The most likely areas of contention are the safety and oversight of remote-site pharmacies, especially the use of registered pharmacy technicians to handle transactions and deliver medications without an on-site pharmacist. Another potential concern is the handling of controlled substances: the bill permits most controlled substances but bars Schedule II dispensing unless a pharmacist is physically present, which may reflect a compromise between access and security. Stakeholders most likely to focus on these issues include pharmacists, pharmacy boards, patient safety advocates, and pharmacy operators seeking expanded staffing flexibility and extended hours.